From molecules to matrix: Construction and evaluation of molecularly defined bioscaffolds

Advances in Experimental Medicine and Biology

Volumn 585, Issue , 2006, Pages 279-295

  Geutjes, Paul J ^a   Daamen, Willeke F ^a   Buma, Pieter ^a   Feitz, Wout F ^a   Faraj, Kaeuis A ^a,b   Van Kuppevelt, Toin H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b European Medical Contract Manufacturing BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934434682     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-34133-0_19     Document Type: Conference Paper

References (61)

1. R.S. Langer and J.P. Vacanti. Tissue engineering: the challenges ahead. Sci Am 280(4), 86-89 (1999).
2. R. Langer and J.P. Vacanti. Tissue engineering. Science 260(5110), 920-926 (1993).
3. L.G. Griffith and G. Naughton. Tissue engineering - current challenges and expanding opportunities. Science 295(5557), 1009-1014 (2002).
4. M.P. Lutolf and J.A. Hubbell. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23(1), 47-55 (2005).
5. W.F. Daamen, H.T. van Moerkerk, T. Hafmans, L. Buttafoco, A.A. Poot, J.H. Veerkamp and T.H. van Kuppevelt. Preparation and evaluation of molecularly-defined collagen-elastin-glycosaminoglycan scaffolds for tissue engineering. Biomaterials 24(22), 4001-4009 (2003).
6. J.A. Hubbell. Materials as morphogenetic guides in tissue engineering. Curr Opin Biotechnol 14(5), 551-558 (2003).
7. G.J. Laurent. Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol 252(1 Pt 1), C1-9 (1987).
8. D.J. Prockop and K.I. Kivirikko. Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem 64403-434 (1995).
9. P.H. Byers. Inherited disorders of collagen gene structure and expression. Am J Med Genet 34(1), 72-80 (1989).
10. F.J. O'Brien, B.A. Harley, I.V. Yannas and L.J. Gibson. The effect of pore size on cell adhesion in collagen-GAG scaffolds. Biomaterials 26(4), 433-441 (2005).
11. Y.S. Pek, M. Spector, I.V. Yannas and L.J. Gibson. Degradation of a collagen-chondroitin-6-sulfate matrix by collagenase and by chondroitinase. Biomaterials 25(3), 473-482 (2004).
12. G. Marmieri, M. Pettenati, C. Cassinelli and M. Morra. Evaluation of slipperiness of catheter surfaces. J Biomed Mater Res 33(1), 29-33 (1996).
13. J.A. Buckwalter and H.J. Mankin. Articular cartilage: tissue design and chondrocyte-matrix interactions. Instr Course Lect 47477-486 (1998).
14. C.M. Kielty, M.J. Sherratt and C.A. Shuttleworth. Elastic fibres. J Cell Sci 115(Pt 14), 2817-2828 (2002).
15. J.D. Berglund, R.M. Nerem and A. Sambanis. Incorporation of intact elastin scaffolds in tissue-engineered collagen-based vascular grafts. Tissue Eng 10(9-10), 1526-1535 (2004).
16. T. Chandy, G.H. Rao, R.F. Wilson and G.S. Das. The development of porous alginate/elastin/PEG composite matrix for cardiovascular engineering. J Biomater Appl 17(4), 287-301 (2003).
17. M. Li, M.J. Mondrinos, M.R. Gandhi, F.K. Ko, A.S. Weiss and P.I. Lelkes. Electrospun protein fibers as matrices for tissue engineering. Biomaterials 26(30), 5999-6008 (2005).
18. C. Kielty, T. Wess, L. Haston, J. Ashworth, M. Sherratt and C. Shuttleworth. Fibrillin-rich microfibrils: elastic biopolymers of the extracellular matrix. Journal of Muscle Research and Cell Motility 23(5-6), 581-596 (2002).
19. R. Raman, V. Sasisekharan and R. Sasisekharan. Structural insights into biological roles of protein-glycosaminoglycan interactions. Chem Biol 12(3), 267-277 (2005).
20. D.R. Coombe and W.C. Kett. Heparan sulfate-protein interactions: therapeutic potential through structure-function insights. Cell Mol Life Sci 62(4), 410-424 (2005).
21. S. Valla, J. Li, H. Ertesvag, T. Barbeyron and U. Lindahl. Hexuronyl C5-epimerases in alginate and glycosaminoglycan biosynthesis. Biochimie 83(8), 819-830 (2001).
22. M.E. Nimni. Polypeptide growth factors: targeted delivery systems. Biomaterials 18(18), 1201-1225 (1997).
23. D.G. Fernig and J.T. Gallagher. Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair. Prog Growth Factor Res 5(4), 353-377 (1994).
24. J.E. Babensee, L.V. McIntire and A.G. Mikos. Growth factor delivery for tissue engineering. Pharm Res 17(5), 497-504 (2000).
25. M. Salmivirta, K. Lidholt and U. Lindahl. Heparan sulfate: a piece of information. Faseb J 10(11), 1270-1279 (1996).
26. A. Perets, Y. Baruch, F. Weisbuch, G. Shoshany, G. Neufeld and S. Cohen. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A 65(4), 489-497 (2003).
27. T. Asahara, C. Bauters, L.P. Zheng, S. Takeshita, S. Bunting, N. Ferrara, J.F. Symes and J.M. Isner. Synergistic Effect of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor on Angiogenesis In Vivo. Circulation 92(9), 365-371 (1995).
28. J.D. Zhang, L.S. Cousens, P.J. Barr and S.R. Sprang. Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta. Proc Natl Acad Sci U S A 88(8), 3446-3450 (1991).
29. N. Ferrara. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 280(6), C1358-1366 (2001).
30. J.S. Pieper, A. Oosterhof, P.J. Dijkstra, J.H. Veerkamp and T.H. van Kuppevelt. Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate. Biomaterials 20(9), 847-858 (1999).
31. J.S. Pieper, P.M. van der Kraan, T. Hafmans, J. Kamp, P. Buma, J.L. van Susante, W.B. van den Berg, J.H. Veerkamp and T.H. van Kuppevelt. Crosslinked type II collagen matrices: preparation, characterization, and potential for cartilage engineering. Biomaterials 23(15), 3183-3192 (2002).
32. W.F. Daamen. Isolation of intact elastin fibres devoid of microfibrils. Tissue Eng 11(7/8), 1168-1176 (2005).
33. W.F. Daamen, T. Hafmans, J.H. Veerkamp and T.H. Van Kuppevelt. Comparison of five procedures for the purification of insoluble elastin. Biomaterials 22(14), 1997-2005 (2001).
34. W.F. Daamen, S.T. Nillesen, T. Hafmans, J.H. Veerkamp, M.J. van Luyn and T.H. van Kuppevelt. Tissue response of defined collagen-elastin scaffolds in young and adult rats with special attention to calcification. Biomaterials 26(1), 81-92 (2005).
35. J.S. Pieper, T. Hafmans, J.H. Veerkamp and T.H. van Kuppevelt. Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects. Biomaterials 21(6), 581-593 (2000).
36. C.H. van de Lest, E.M. Versteeg, J.H. Veerkamp and T.H. van Kuppevelt. Quantification and characterization of glycosaminoglycans at the nanogram level by a combined azure A-silver staining in agarose gels. Anal Biochem 221(2), 356-361 (1994).
37. C.H. van de Lest, E.M. Versteeg, J.H. Veerkamp and T.H. van Kuppevelt. A spectrophotometric method for the determination of heparan sulfate. Biochim Biophys Acta 1201(2), 305-311 (1994).
38. J.S. Pieper, T. Hafmans, P.B. van Wachem, M.J. van Luyn, L.A. Brouwer, J.H. Veerkamp and T.H. van Kuppevelt. Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. J Biomed Mater Res 62(2), 185-194 (2002).
39. F.J. O'Brien, B.A. Harley, I.V. Yannas and L. Gibson. Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds. Biomaterials 25(6), 1077-1086 (2004).
40. L.H.H. Olde Damink, P.J. Dijkstra, M.J.A. van Luyn, P.B. van Wachem, P. Nieuwenhuis and J. Feijen. Cross-linking of dermal sheep collagen using a water-soluble carbodiimide. Biomaterials 17(8), 765-773 (1996).
41. I.V. Yannas and J.F. Burke. Design of an artificial skin. I. Basic design principles. J Biomed Mater Res 14(1), 65-81 (1980).
42. T.H. van Kuppevelt, M.A. Dennissen, W.J. van Venrooij, R.M. Hoet and J.H. Veerkamp. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J Biol Chem 273(21), 12960-12966 (1998).
43. J.S. Pieper, P.B. van Wachem, M.J.A. van Luyn, L.A. Brouwer, T. Hafmans, J.H. Veerkamp and T.H. van Kuppevelt. Attachment of glycosaminoglycans to collagenous matrices modulates the tissue response in rats. Biomaterials 21(16), 1689-1699 (2000).
44. J.E. Nuininga, H. van Moerkerk, A. Hanssen, C.A. Hulsbergen, J. Oosterwijk-Wakka, E. Oosterwijk, R.P. de Gier, J.A. Schalken, T.H. van Kuppevelt and W.F. Feitz. A rabbit model to tissue engineer the bladder. Biomaterials 25(9), 1657-1661 (2004).
45. F. Oberpenning, J. Meng, J.J. Yoo and A. Atala. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. 17(2), 149-155 (1999).
46. S.V. Lima, L.A. Araujo, F.O. Vilar, C.L. Kummer and E.C. Lima. Nonsecretory sigmoid cystoplasty: experimental and clinical results. J Urol 153(5), 1651-1654 (1995).
47. N. Arikan, K. Turkolmez, M. Budak and O. Gogus. Outcome of augmentation sigmoidocystoplasty in children with neurogenic bladder. Urol Int 64(2), 82-85 (2000).
48. S. Herschorn and R.J. Hewitt. Patient perspective of long-term outcome of augmentation cystoplasty for neurogenic bladder. Urology 52(4), 672-678 (1998).
49. A. Atala. Regenerative medicine and urology. BJU Int 92 Suppl 158-67 (2003).
50. P.A. Merguerian, P.P. Reddy, D.J. Barrieras, G.J. Wilson, K. Woodhouse, D.J. Bagli, G.A. McLorie and A.E. Khoury. Acellular bladder matrix allografts in the regeneration of functional bladders: evaluation of large-segment (> 24 cm) substitution in a porcine model. BJU Int 85(7), 894-898 (2000).
51. M. Probst, R. Dahiya, S. Carrier and E.A. Tanagho. Reproduction of functional smooth muscle tissue and partial bladder replacement. Br J Urol 79(4), 505-515 (1997).
52. B.P. Kropp, B.L. Eppley, C.D. Prevel, M.K. Rippy, R.C. Harruff, S.F. Badylak, M.C. Adams, R.C. Rink and M.A. Keating. Experimental assessment of small intestinal submucosa as a bladder wall substitute. Urology 46(3), 396-400 (1995).
53. B.P. Kropp. Small-intestinal submucosa for bladder augmentation: a review of preclinical studies. World J Urol 16(4), 262-267 (1998).
54. P.P. Reddy, D.J. Barrieras, G. Wilson, D.J. Bagli, G.A. McLorie, A.E. Khoury and P.A. Merguerian. Regeneration of functional bladder substitutes using large segment acellular matrix allografts in a porcine model. J Urol 164(3 Pt 2), 936-941 (2000).
55. P. Buma, J.S. Pieper, T. van Tienen, J.L. van Susante, P.M. van der Kraan, J.H. Veerkamp, W.B. van den Berg, R.P. Veth and T.H. van Kuppevelt. Cross-linked type I and type II collagenous matrices for the repair of full-thickness articular cartilage defects - a study in rabbits. Biomaterials 24(19), 3255-3263 (2003).
56. P.M.D. Nastaran Mahmoudifar. Tissue engineering of human cartilage in bioreactors using single and composite cell-seeded scaffolds. Biotechnology and Bioengineering 91(3), 338-355 (2005).
57. R. Westreich, M. Kaufman, P. Gannon and W. Lawson. Validating the subcutaneous model of injectable autologous cartilage using a fibrin glue scaffold. Laryngoscope 114(12), 2154-2160 (2004).
58. S.W. Kang, O. Jeon and B.S. Kim. Poly(lactic-co-glycolic acid) microspheres as an injectable scaffold for cartilage tissue engineering. Tissue Eng 11(3-4), 438-447 (2005).
59. J.S. Dounchis, W.C. Bae, A.C. Chen, R.L. Sah, R.D. Coutts and D. Amiel. Cartilage repair with autogenic perichondrium cell and polylactic acid grafts. Clin Orthop Relat Res(377), 248-264 (2000).
60. S.B. Cohen, C.M. Meirisch, H.A. Wilson and D.R. Diduch. The use of absorbable co-polymer pads with alginate and cells for articular cartilage repair in rabbits. Biomaterials 24(15), 2653-2660 (2003).
61. H.A. Breinan, S.D. Martin, H.P. Hsu and M. Spector. Healing of canine articular cartilage defects treated with microfracture, a type-II collagen matrix, or cultured autologous chondrocytes. J Orthop Res 18(5), 781-789 (2000).